---
title: "GLORIA PHARMA: Injectable multiple vitamins pass consistency evaluation"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/245860215.md"
description: "GLORIA PHARMA announced that its wholly-owned subsidiary, Pude Pharmaceutical, has received the Drug Supplement Application Approval Notice issued by the National Medical Products Administration for injectable multivitamins. This drug has passed the consistency evaluation of the quality and efficacy of generic drugs. Injectable multivitamins are suitable for adult patients and children over 11 years old, with sales expected to reach RMB 1.916 billion in urban public hospitals and county-level public medical institutions in China in 2024. Pude Pharmaceutical has invested approximately RMB 3.6706 million in the consistency evaluation work for this drug"
datetime: "2025-06-24T09:34:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/245860215.md)
  - [en](https://longbridge.com/en/news/245860215.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/245860215.md)
generator: "portal-rs"
---

# GLORIA PHARMA: Injectable multiple vitamins pass consistency evaluation

GLORIA PHARMA announced that its wholly-owned subsidiary, Pude Pharmaceutical, has received the approval notice for the supplementary application of injectable multivitamins issued by the National Medical Products Administration. This drug has passed the consistency evaluation of quality and efficacy for generic drugs. Injectable multivitamins are suitable for adult patients and children over 11 years old, with sales expected to reach 1.916 billion yuan in urban public hospitals and county-level public medical institutions in China in 2024. Pude Pharmaceutical has invested approximately 3.6706 million yuan in the consistency evaluation work for this drug

### Related Stocks

- [002437.CN](https://longbridge.com/en/quote/002437.CN.md)

## Related News & Research

- [LEAD Launch Leaves Accountable Care Technology Buyers Little Time for a Wrong Decision, Q3 Study](https://longbridge.com/en/news/296106866.md)
- [CSPC Innovation Pharmaceutical: Biopharma licensing and product launches drove record revenue and profit growth](https://longbridge.com/en/news/296129143.md)
- [SandboxAQ introduces AQPotency for virtual drug screening](https://longbridge.com/en/news/296467103.md)
- [Curql invests in pet healthcare platform Wagmo](https://longbridge.com/en/news/296396050.md)
- [Standard Uranium flags 55 meters of uranium enrichment at Corvo project in Saskatchewan](https://longbridge.com/en/news/296483204.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**